The amniotic material is obtained from consenting donors after a scheduled C-section. The babies are fine and no embryonic stem cells are used. The material is acquired in a sterile fashion and then processed at an FDA regulated lab.
For amniotic fluid, it is cryogenically frozen once processing is complete which preserves cell viability. It is kept frozen at -82 degrees Celsius until it needs to be used. Shipping occurs on dry ice to keep frozen.
For placental amniotic membrane, the products are minimally manipulated, dehydrated, non-viable cellular amniotic membrane allografts that contain multiple extracellular matrix proteins, growth factors, cytokines and other specialty proteins present in amniotic tissue to provide a barrier membrane that enhances healing. The product is sterile in the packaging and kept at room temperature.